145 related articles for article (PubMed ID: 2180599)
1. Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor.
Davis TA; Monroy RL; Skelly RR; Donahue RE; MacVittie TJ
Clin Exp Immunol; 1990 Mar; 79(3):436-42. PubMed ID: 2180599
[TBL] [Abstract][Full Text] [Related]
2. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys.
Krumwieh D; Weinmann E; Siebold B; Seiler FR
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():229-47; discussion 247-8. PubMed ID: 1691245
[TBL] [Abstract][Full Text] [Related]
4. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates.
Mayer P; Valent P; Schmidt G; Liehl E; Bettelheim P
Blood; 1989 Aug; 74(2):613-21. PubMed ID: 2665851
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.
Singh SM; Sone S; Inamura N; Ogura T
Int J Cancer; 1989 Jul; 44(1):170-6. PubMed ID: 2663733
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
7. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
8. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
Herbelin A; Machavoine F; Dy M
Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of monocytes to lymphokine-activated killer cell lysis: effect of granulocyte-macrophage colony-stimulating factor and interleukin-3.
Djeu JY; Widen R; Blanchard DK
Blood; 1989 Apr; 73(5):1264-71. PubMed ID: 2649172
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
11. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
12. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
Moore MA; Stolfi RL; Martin DS
J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
15. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
16. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia.
Farese AM; Williams DE; Seiler FR; MacVittie TJ
Blood; 1993 Nov; 82(10):3012-8. PubMed ID: 8219192
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human macrophage colony-stimulating factor (M-CSF) requires subliminal concentrations of granulocyte/macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro.
Caracciolo D; Shirsat N; Wong GG; Lange B; Clark S; Rovera G
J Exp Med; 1987 Dec; 166(6):1851-60. PubMed ID: 2445896
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.
van den Bosch G; Preijers F; Vreugdenhil A; Hendriks J; Maas F; De Witte T
Clin Exp Immunol; 1995 Sep; 101(3):515-20. PubMed ID: 7664499
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
